![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels
LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels
Read moreTue, 23rd Jun 2020 10:14
LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels
Read more(Sharecast News) - Silence Therapeutics announced on Friday that it would receive a $2m (£1.43m) milestone payment following the start of work on a third target being explored under its ongoing RNAi research collaboration with Mallinckrodt, for the treatment of complement pathway-mediated diseases.
Read moreIN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial
Read more(Sharecast News) - Silence Therapeutics has started dosing subjects in the 'APOLLO' phase 1 clinical study of its wholly-owned lead product candidate 'SLN360', it announced on Wednesday, for the treatment of elevated lipoprotein-a (Lp(a)) levels.
Read moreSilence Therapeutics Raises USD45 Million In Private Share Placing
Read more(Sharecast News) - Novel therapeutics developer Silence Therapeutics announced an oversubscribed private placement of 2,022,218 American depositary shares (ADSs) on Friday, raising £33m to support the development of its pipeline.
Read moreUK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile
Read more(Sharecast News) - Drug discovery outfit Silence Therapeutics has named Craig Tooman as its new chief financial officer.
Read moreUK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares
Read moree-Therapeutics Names New Chief Executive; Plans To Ramp Up Research
Read moreUK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float
Read moreSilence Therapeutics Appoints Mark Rothera As CEO; Annual Loss Widens
Read more(Sharecast News) - Drug discovery and development company Silence Therapeutics announced the appointment of Mark Rothera as its president and chief executive officer and board member on Monday, effective immediately.
Read moreIN BRIEF: Silence Therapeutics ADSs Begin Life On Nasdaq
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more